All In Biotech

Investigational drug · Phase 2

BRIMOCHOL PF eye drops

Also called: CARBACHOL PF eye drops, Brimonidine tartrate eye drops

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Presbyopia, Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive.

Phase 2

Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

3

Any phase or sponsor naming "BRIMOCHOL PF eye drops"

First trial start

2024

Jul 29, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "BRIMOCHOL PF eye drops", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Presbyopia
  • Recurrent Ovarian Cancer
  • Folate Receptor-Alpha Positive

Approved drugs for the same conditions: Ovarian cancer · Oncology · Ophthalmology

Largest trials

Live from ClinicalTrials.gov: studies naming "BRIMOCHOL PF eye drops" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 9 on PubMed

Also in development for Presbyopia

  • phentolamine vehiclePhase 32 trials

    Opus Genetics, Inc · Mesopic Vision, Night Vision Loss, Presbyopia

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.